Professor Andreas Obermair
Professor

Andreas Obermair

Email: 
Phone: 
+61 7 334 66044

Background

Professor Obermair is the Director of Queensland Centre for Gynaecological Cancer Research (QCGC Research). He is a Professor of Gynaecological Oncology since 2007, a Senior Medical Officer at Royal Brisbane & Women’s Hospital and a Visiting Medical Officer at St Andrews War Memorial Hospital and Buderim Private Hospital. He holds an Honorary title of Professor at UQ since 2006.

Professor Obermair is an internationally recognised leader in gynaecological oncology research and treatment and has lead the research team at QCGC Research since establishing it in 2003.

Availability

Professor Andreas Obermair is:
Available for supervision

Fields of research

Biological Sciences Biomedical and Clinical Sciences Health Sciences Medical microbiology Oncology and carcinogenesis

Qualifications

  • Doctoral Diploma of Medicine, International University Vienna
  • Royal Australian and New Zealand College of Obstetricians and Gynaecologists, Royal Australian and New Zealand College of Obstetricians and Gynaecologists

Research interests

  • Clinical Trials

    Decisions on cancer management ideally are based on the results of high-level evidence, obtained through clinical trials whenever possible. As a principle, a new (proposed better) intervention should be compared to the current standard treatment before being made available generally. Outside a clinical trial new treatments should not become available until evidence has become available to demonstrate superiority over the current standard treatment. Retrospective studies harbour the risk that biases influenced outcomes. At QCGC Research we engage in phase 2 and 3 clinical trials. In large phase trials, patients are allocated randomly to one of two or more interventions in order to minimise the risk of bias. Generally, patients treated within clinical trials have a better outcome compared to patients who are not treated in clinical trials. As the Director of Research Gynaecological Oncology I am currently involved in developing and managing clinical trials in gynaecological cancers.

  • Translational Research

    The focus of QCGC Research's translational research program is the application of new technology (molecular, biochemical, imaging and surgical) to prevention, detection and therapy for gynaecological cancers.

  • Quality of Life Research

    Cancer specialists are aware that not only the survival time but also the quality of life is a key factor in cancer treatment. This is especially important when two treatments are equally effective but cause different side-effects. My Quality-of-Life research focuses on ovarian, endometrial, cervical and vulval cancer. I wish to provide the best, most effective and modern treatment to my patients with least possible detriments to quality of life.

  • Minimally Invasive Surgery

    In Australia, around 30,000 hysterectomies are conducted annually to treat uterine cancer and various benign gynaecological conditions. While open abdominal surgery may be necessary in around 10% of cases, evidence shows that less-invasive approaches, such as total laparoscopic hysterectomy (TLH) can achieve better outcomes for women at a lower overall cost to the health system. Yet, in Queensland, four of ten hysterectomies are still conducted by open abdominal surgery. Our own research has shown that many Australian surgeons are keen to adopt new techniques such as TLH, but that the lack of systematic training and mentoring opportunities is the main impediment to practice-change. Together with gynaecological surgical teams at hospitals and industry support we developed a prototype for system-level transformative practice change in gynaecological surgery.

Research impacts

Professor Obermair is an innovative and skilled gynaecologic oncologist, surgical teacher and consumer advocate. His international leadership and research impact was acknowledged in 2020 by the Australian community, when he was awarded an NHMRC Investigator Fellowship Level 2 (2021-25). The national impact of his research was recognised in 2017, when he was awarded Cancer Australia’s Jeannie Ferris Recognition Award (2017), for outstanding achievements in clinical practice and research. He is deeply engaged in consumer involvement and co-founded and serves on the Board of the Cherish Foundation, a consumer-focussed organisation that funds clinical research in better treatments for women with gynaecological cancers.

Search Professor Andreas Obermair’s works on UQ eSpace

360 works between 1991 and 2025
All (360) Journal Article (317) Book Chapter (1) Conference Publication (41) Other Outputs (1)

321 - 340 of 360 works

1997

Journal Article

In vitro cytokine and prostaglandin production by amnion cells in the presence of bacteria

Reisenberger, K, Egarter, C, Schiebel, I, Obermair, A, Kiss, H and Lehner, R (1997). In vitro cytokine and prostaglandin production by amnion cells in the presence of bacteria. American Journal of Obstetrics and Gynecology, 176 (5), 981-984. doi: 10.1016/S0002-9378(97)70389-2

In vitro cytokine and prostaglandin production by amnion cells in the presence of bacteria

1997

Journal Article

Angiogenesis in vulvar intraepithelial neoplasia

Banchertodesca, D, Obermair, A, Bilgi, S, Kohlberger, P, Kainz, C, Breitenecker, G, Leodolter, S and Gitsch, G (1997). Angiogenesis in vulvar intraepithelial neoplasia. Gynecologic Oncology, 64 (3), 496-500. doi: 10.1006/gyno.1996.4582

Angiogenesis in vulvar intraepithelial neoplasia

1997

Journal Article

Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium

Marth, C, Windbichler, G, Petru, E, Dirschlmayer, W, Obermair, A, Czerwenka, K, MullerHolzner, E and Dapunt, O (1997). Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium. Gynecologic Oncology, 64 (1), 121-125. doi: 10.1006/gyno.1996.4538

Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium

1997

Journal Article

Computer-assisted image analysis of vascularity - Reply

Kohlberger, P, Obermair, A, Kainz, C and Breitenecker, G (1997). Computer-assisted image analysis of vascularity - Reply. American Journal of Clinical Pathology, 107 (1), 132-133.

Computer-assisted image analysis of vascularity - Reply

1996

Journal Article

Influence of delayed on established prognostic factors in endometrial cancer

Obermair, Andreas, Hanzal, Engelbert, Schreiner-Frech, Inge, Buxbaum, Pia, Bancher-Todesca, Dagmar, Thoma, Martin, Kurz, Christine, Vavra, Norbert, Gitsch, Gerald and Sevelda, Paul (1996). Influence of delayed on established prognostic factors in endometrial cancer. Anticancer Research, 16 (2), 947-950.

Influence of delayed on established prognostic factors in endometrial cancer

1996

Journal Article

Behcet's disease of the uterine cervic - A case report M. Behcet der Cervix uteri - Ein Fallbericht

Bancher-Todesca, Dagmar, Seeber, A., Tempfer, C., Obermair, A., Kucera, E., Gitsch, G. and Kainz, C. (1996). Behcet's disease of the uterine cervic - A case report M. Behcet der Cervix uteri - Ein Fallbericht. Wiener Klinische Wochenschrift, 108 (21), 689-691.

Behcet's disease of the uterine cervic - A case report M. Behcet der Cervix uteri - Ein Fallbericht

1996

Journal Article

Behcet's disease of the uterine cervix - A case report

Banchertodesca, D, Seeber, A, Tempfer, C, Obermair, A, Kucera, E, Gitsch, G and Kainz, C (1996). Behcet's disease of the uterine cervix - A case report. Wiener Klinische Wochenschrift, 108 (21), 689-691.

Behcet's disease of the uterine cervix - A case report

1996

Journal Article

Influence of microvessel density and vascular permeability factor vascular endothelial growth factor expression on prognosis in vulvar cancer

Obermair, A, Kohlberger, P, BancherTodesca, D, Tempfer, C, Sliutz, G, Leodolter, S, Reinthaller, A, Kainz, C, Breitenecker, G and Gitsch, G (1996). Influence of microvessel density and vascular permeability factor vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecologic Oncology, 63 (2), 204-209. doi: 10.1006/gyno.1996.0307

Influence of microvessel density and vascular permeability factor vascular endothelial growth factor expression on prognosis in vulvar cancer

1996

Journal Article

Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma - A comparison of computer-assisted image analysis with established counting methods

Kohlberger, PD, Obermair, A, Sliutz, G, Heinzl, H, Koelbl, H, Breitenecker, G, Gitsch, G and Kainz, C (1996). Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma - A comparison of computer-assisted image analysis with established counting methods. American Journal of Clinical Pathology, 105 (6), 705-710. doi: 10.1093/ajcp/105.6.705

Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma - A comparison of computer-assisted image analysis with established counting methods

1996

Journal Article

Influence of delayed diagnosis on established prognostic factors in endometrial cancer

Obermair, A, Hanzal, E, SchreinerFrech, I, Buxbaum, P, BancherTodesca, D, Thoma, M, Kurz, C, Vavra, N, Gitsch, G and Sevelda, P (1996). Influence of delayed diagnosis on established prognostic factors in endometrial cancer. Anticancer Research, 16 (2), 947-949.

Influence of delayed diagnosis on established prognostic factors in endometrial cancer

1995

Journal Article

Serum evaluation of basic FGF in breast cancer patients

Sliutz, G, Tempfer, C, Obermair, A, Dadak, C and Kainz, C (1995). Serum evaluation of basic FGF in breast cancer patients. Anticancer Research, 15 (6B), 2675-2677.

Serum evaluation of basic FGF in breast cancer patients

1995

Journal Article

The influence of obesity on the disease-free survival in primary breast cancer

Obermair, A, Kurz, C, Hanzal, E, BancherTodesca, D, Thoma, M, Bodisch, A, Kubista, E, Kyral, E, Kaider, A, Sevelda, P and Gitsch, G (1995). The influence of obesity on the disease-free survival in primary breast cancer. Anticancer Research, 15 (5B), 2265-2269.

The influence of obesity on the disease-free survival in primary breast cancer

1995

Journal Article

Serum Evaluation of Basic Fibroblast Growth-Factor in Cervical-Cancer Patients

Sliutz, G, Tempfer, C, Obermair, A, Reinthaller, A, Gitsch, G and Kainz, C (1995). Serum Evaluation of Basic Fibroblast Growth-Factor in Cervical-Cancer Patients. Cancer Letters, 94 (2), 227-231. doi: 10.1016/0304-3835(95)03853-O

Serum Evaluation of Basic Fibroblast Growth-Factor in Cervical-Cancer Patients

1995

Journal Article

Microvessel Density and Vessel Invasion in Lymph-Node-Negative Breast-Cancer - Effect On Recurrence-Free Survival

Obermair, A, Kurz, C, Czerwenka, K, Thoma, M, Kaider, A, Wagner, T, Gitsch, G and Sevelda, P (1995). Microvessel Density and Vessel Invasion in Lymph-Node-Negative Breast-Cancer - Effect On Recurrence-Free Survival. International Journal of Cancer, 62 (2), 126-131. doi: 10.1002/ijc.2910620203

Microvessel Density and Vessel Invasion in Lymph-Node-Negative Breast-Cancer - Effect On Recurrence-Free Survival

1995

Journal Article

Prognostic Value of Tumor Microvessel Density in Cancer of the Uterine Cervix Stage Ib to Iib

Kainz, C, Speiser, P, Wanner, C, Obermair, A, Tempfer, C, Sliutz, G, Reinthaller, A and Breitenecker, G (1995). Prognostic Value of Tumor Microvessel Density in Cancer of the Uterine Cervix Stage Ib to Iib. Anticancer Research, 15 (4), 1549-1551.

Prognostic Value of Tumor Microvessel Density in Cancer of the Uterine Cervix Stage Ib to Iib

1995

Journal Article

Onycholysis of the finger and toenails following the application of high-dose oral etoposide (1250 mg/m2) given as 200- and 150-mg single doses from days 1-10 every 3 weeks

Obermair, A., Vavra, N., Kurz, C., Helmer, H., Sevelda, P. and Pehamberger, K. (1995). Onycholysis of the finger and toenails following the application of high-dose oral etoposide (1250 mg/m2) given as 200- and 150-mg single doses from days 1-10 every 3 weeks. Gynecologic Oncology, 57 (3)

Onycholysis of the finger and toenails following the application of high-dose oral etoposide (1250 mg/m2) given as 200- and 150-mg single doses from days 1-10 every 3 weeks

1995

Journal Article

Untitled

Obermair, A, Vavra, N, Kurz, C, Helmer, H, Sevelda, P and Pehamberger, K (1995). Untitled. Gynecologic Oncology, 57 (3), 436-436.

Untitled

1995

Journal Article

Tumor Microvessel Density in Breast-Cancer and its Influence On Recurrence-Free Survival - Reply

Obermair, A (1995). Tumor Microvessel Density in Breast-Cancer and its Influence On Recurrence-Free Survival - Reply. Chirurg, 66 (1), 77-77.

Tumor Microvessel Density in Breast-Cancer and its Influence On Recurrence-Free Survival - Reply

1995

Journal Article

Letter to the editor [1]

Obermair, A., Vavra, N., Kurz, C., Helmer, H., Sevelda, P. and Pehamberger, K. (1995). Letter to the editor [1]. Gynecologic Oncology, 57 (3), 436-438. doi: 10.1006/gyno.1995.1170

Letter to the editor [1]

1994

Conference Publication

Delayed diagnosis of advanced endometrial carcinoma

Buxbaum, P, Obermair, A, Schreinerfrech, I, Kurz, C, Vavra, N and Sevelda, P (1994). Delayed diagnosis of advanced endometrial carcinoma. Annual Meeting of the Osterreichischen-Gesellschaft-fur-Gynakologie-und-Geburtshilfe, Bregenz Austria, Jun, 1994. BASEL: KARGER. doi: 10.1159/000272749

Delayed diagnosis of advanced endometrial carcinoma

Current funding

  • 2026 - 2030
    Towards evidence-supported precision surgery for gynaecological cancer
    NHMRC Investigator Grants
    Open grant
  • 2025 - 2030
    Centre of Research Excellence to Improve the QuALIty of SurVival in Gynaecological Cancer PatiEnts (ALIVE WELL)
    NHMRC Centres of Research Excellence
    Open grant
  • 2025 - 2026
    The Australian National Vulvar Cancer (ANVU) trial: A Phase II clinical trial of groin ultrasound surveillance to de-escalate surgical intervention in vulvar cancer
    Cherish Women's Cancer Foundation
    Open grant
  • 2024 - 2029
    The EARLY study: Evaluating the Specificity and feasibility of the EARLY Test for Ovarian Cancer Detetion
    NHMRC Partnership Projects
    Open grant
  • 2024 - 2027
    Moving without fear when living with stoma: A consumer-led physical activity study (MRFF CLR Grant administered by Griffith University)
    Open grant
  • 2024 - 2029
    Salpingectomy with delayed oophorectomy to prevent ovarian cancer (TUBA WISP II) (MRFF ICTC Grant led by University of Melbourne)
    University of Melbourne
    Open grant
  • 2024 - 2025
    EN.10 - A Phase II study of adjuvant therapy in pole-mutated and p53-wildtype/NSWP early stage endometrial cancer (RAINBO BLUE & TAPER)
    Australia New Zealand Gynaecological Oncology Group
    Open grant
  • 2024 - 2025
    Queensland Centre for Gynaecological Cancer's NODE Study
    Gynaecological Cancer Research, Education and Development Society Limited Research Grant
    Open grant
  • 2024 - 2028
    ENDO3:A Phase III Randomised Controlled Clinical Trial Comparing Disease-Free Survival of Patients with or without Lymph Node Dissection in clinical stage I Endometrial Cancer (ANZGOGtrial #1911/2020)
    NHMRC Clinical Trials and Cohort Studies Grants
    Open grant
  • 2024 - 2025
    Feasibility testing Of telehealth-delivered eXercise Therapy for Ostomates Treated for cancer (FOXTROT)
    Wesley Research Institute Ltd
    Open grant
  • 2023 - 2028
    Vulvar Cancer Feasibility Study: Establishing a novel pathway to best-practice treatment in vulvar cancer
    Research Donation Generic
    Open grant
  • 2022 - 2026
    A non-surgical alternative to hysterectomy for the treatment of endometrial cancer
    NHMRC Partnership Projects
    Open grant
  • 2021 - 2025
    Creating treatment options for endometrial cancer through high-level clinical trials
    NHMRC Investigator Grants
    Open grant
  • 2010 - 2025
    QCOG (Data Manager Grant)
    Cancer Council Queensland
    Open grant

Past funding

  • 2024
    Moving without fear when living with stoma: A consumer-led physical activity study
    NHMRC MRFF PPHR - Consumer Led Research
    Open grant
  • 2024
    Improving quality of life for vulvar cancer patients through non-invasive interventions
    Metro North Hospital and Health Service
    Open grant
  • 2021 - 2024
    MOST (Measure of Ovarian Symptoms and Treatment concerns)
    St John of God Healthcare Inc
    Open grant
  • 2020 - 2022
    A Phase III Randomised Clinical Trial Comparing Patient Outcomes of Sentinel Lymph Node Dissection in Endometrial Cancer (ENDO-3PRO trial)
    Cherish Women's Cancer Foundation
    Open grant
  • 2020 - 2024
    A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancer (MRFF EPCDR administered by Griffith).
    Griffith University
    Open grant
  • 2020 - 2023
    Implementing non-surgical options for endometrial cancer treatment into clinical practice
    ICON Cancer Care
    Open grant
  • 2020 - 2021
    A Phase III Randomised Clinical Trial Comparing Sentinel Node Biopsy with No Retroperitoneal Node Dissection in Early-Stage Endometrial Cancer (ENDO-3)
    Metro North Hospital and Health Service
    Open grant
  • 2019 - 2020
    feMMe Long Term Follow-Up study
    ASGO Research Grants
    Open grant
  • 2019 - 2020
    A Phase III Randomised Clinical Trial Comparing Sentinel Node Biopsy with No Retroperitoneal Node Dissection in Early-Stage Endometrial Cancer (ENDO-3)
    Gynaecological Cancer Research, Education and Development Society Limited Research Grant
    Open grant
  • 2017 - 2020
    The Implementation of MinimAlly INvasivE hysterectomy (IMAGINE) trial
    NHMRC Partnership Projects
    Open grant
  • 2017 - 2018
    Transforming surgical practice through innovation IMAGINE
    Metro North Hospital and Health Service
    Open grant
  • 2017 - 2021
    The ECHO trial: Exercise during CHemotherapy for Ovarian cancer (World Cancer Research Fund International grant administered by QUT)
    Queensland University of Technology
    Open grant
  • 2017 - 2021
    The Ovarian Cancer Prognosis and Lifestyle (OPAL) Study: Long-term outcomes (NHMRC Project Grant administered by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2016 - 2018
    Long-term follow-up of the Laparoscopic Approach to Carcinoma of the Endometrium (LACE) Trial - survival outcomes
    Cancer Australia
    Open grant
  • 2016
    QCOG 2016
    Cancer Council Queensland
    Open grant
  • 2015 - 2019
    Cherish women's cancer foundation research fellow funding
    Cherish Women's Cancer Foundation
    Open grant
  • 2015 - 2022
    ECHO trial: Exercise during Chemotherapy for Ovarian cancer (Cancer Australia grant administered by The University of Sydney)
    University of Sydney
    Open grant
  • 2015 - 2018
    The fEMMe trial
    Cancer Australia
    Open grant
  • 2015 - 2016
    In Memory of Denise Marcella Collins
    Research Donation Generic
    Open grant
  • 2015 - 2016
    Impact of gated PET/CT on the diagnosis of distant metastases of advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer
    Royal Brisbane and Women's Hospital
    Open grant
  • 2015 - 2019
    Selective targeting of adjuvant therapy for endometrial cancer: the STATEC trial (NHMRC Project Grant administered by University of Sydney)
    University of Sydney
    Open grant
  • 2014 - 2015
    A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients with Early Stage Cancer of the Endometrium
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2014 - 2015
    Barriers of the uptake of laparoscopic hysterectomy
    Australian Centre for Health Services Innovation
    Open grant
  • 2014 - 2015
    A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients with Early Stage Cancer of the Endometrium
    Australia New Zealand Gynaecological Oncology Group
    Open grant
  • 2014 - 2015
    Prophylactic surgery and breast cancer
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2013 - 2020
    ACRF Molecular Oncology Translational Imaging Facility (MOTIF)
    Australian Cancer Research Foundation
    Open grant
  • 2013 - 2016
    Mirena ±Weight Loss to treat early Endometrial Cancer (MAxWEL Trial - Cancer Australia grant administered by Queensland University of Technology)
    Queensland University of Technology
    Open grant
  • 2013
    A phase II randomised clinical trial of mirena +/- metformin in patients with early stage cancer of the endometrium
    Royal Brisbane and Women's Hospital
    Open grant
  • 2013
    QCOG 2013 (Data Manager Grants)
    Cancer Council Queensland
    Open grant
  • 2012 - 2023
    In Memory of Jan Sanders and other philanthropic donations
    Research Donation Generic
    Open grant
  • 2012 - 2013
    LEGS follow-up: Lymphoedema Evaluation following Gynaecology Cancer Study
    Queensland University of Technology
    Open grant
  • 2012 - 2013
    The effect of prophylactic, risk-reducing gynaecological surgery on survival among patients with a history of breast cancer
    Royal Brisbane and Women's Hospital
    Open grant
  • 2011 - 2012
    HE 4 Collaborative Study
    Abbott Australasia Pty Ltd
    Open grant
  • 2011
    LEGS:Lymphoedema Evaluation in Gynaecological Cancer Study
    Royal Brisbane and Women's Hospital
    Open grant
  • 2011 - 2012
    Postoperative Enteral Nutrition in Patients with Advanced Epithelial Ovarian Cancer
    Wesley Merdical Research
    Open grant
  • 2010 - 2023
    A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy versus Abdominal radical hysterectomy in patients with early stage cervical cancer (Clinical Trial Agreement)
    University of Texas M.D. Anderson Cancer Centre
    Open grant
  • 2010 - 2013
    Laparoscopic Approach to Carcinoma of the Endometrium. An international multicentre randomised Phase 3 clinical trial
    Cancer Australia
    Open grant
  • 2010 - 2013
    Postoperative Enteral Nutrition in Patients with Advanced Epithelial Ovarian Cancer
    Cancer Australia
    Open grant
  • 2009 - 2011
    National Gynaecological Cancers Service Delivery and Resources Framework
    Cancer Australia
    Open grant
  • 2009 - 2012
    Mayne Bequest Fund Research Support Award: Research & development into better standard of care for women experiencing gynaecological cancer
    Mayne Bequest Fund
    Open grant
  • 2009 - 2012
    A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Patients with Early Stage Cervical Cancer
    University of Texas M.D. Anderson Cancer Centre
    Open grant
  • 2009 - 2010
    Cancer Clinical Trial Data Management Grant 2009
    Cancer Council Queensland
    Open grant
  • 2009 - 2010
    Post-operative enteral nutrition among patients with ovarian cancer
    Gallipoli Research Foundation
    Open grant
  • 2009
    Prognostic value of preoperative CA125 in ovarian tumours of low malignant potential
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2009 - 2010
    Prospective evaluation of lymphoedema among patients with gynaecological cancer
    Gallipoli Research Foundation
    Open grant
  • 2008 - 2011
    Prospective evaluation of lymphoedema among patients with gynaecological cancer
    Wesley Merdical Research
    Open grant
  • 2008 - 2011
    Prospective evaluation of lymphoedema among patients with gynaecological cancer
    Cancer Australia
    Open grant
  • 2008 - 2009
    LACE - Laparoscopic Approach to Carcinoma of the Endometrium - An International Multicentre Randomised Phase 3 Clinical Trial
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2008
    Cancer Clinical Trial Data Management grant 2008
    Queensland Cancer Fund
    Open grant
  • 2008
    Laparoscopic approach to cervical carcinoma -a phase III randomised clinical trial of laparoscopic radical hysterectomy versus abdominal radical hysterectomy in patients w/ early stage cervical cancer
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2007 - 2009
    Total Laparoscopic hysterectomy for Endometrial Cancer
    Queensland Health Smart Health Research Grant
    Open grant
  • 2007
    Cancer Clinical Trial Data Manager, QLD Centre for Gynaecological cancer - 2007
    Queensland Cancer Fund
    Open grant
  • 2007
    LACE- Laparoscopic approach to carcinoma of the endometrium - An international multicentre randomised phase 3 clinical trial - Top-Up funding
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2007 - 2009
    Total Laparoscopic Hysterectomy (TLH) vs. Total Abdominal Hysterectomy (TAH) for the Treatment of Endometrial Cancer
    NHMRC Project Grant
    Open grant
  • 2006
    Cancer Clinical Trial Data Manager at the QLD Centre for Gynaecological Cancer
    Queensland Cancer Fund
    Open grant
  • 2006
    LACE - Laparoscopic approach to carinoma of the endometrium - An International Multicentre Randomised Phase 3 Clinical Trial
    Queensland Cancer Fund
    Open grant
  • 2006 - 2007
    Total laparoscopic hysterectomy (TLH) vs Total Abdominal Hysterectomy (TAH) for the treatment of endometrial cancer
    Queensland Cancer Fund
    Open grant
  • 2005 - 2006
    Clinical Trial Data Manager
    Queensland Cancer Fund
    Open grant
  • 2005 - 2006
    Start-up Grant
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2004 - 2007
    Gynaecological Cancer Society Research Grants
    Gynaecological Cancer Society
    Open grant
  • 2004
    Mismatch repair gene defects in endometrial cancer patients less than 50 years of age
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant

Availability

Professor Andreas Obermair is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • feMMe: Uterus-preserving treatment of endometrial cancer

    In 2020 we completed the feMMe, phase 2 cliniccal trial which established anticancer activity of levonorgestrel intrauterrine device (LNG-IUD) to treat endometrial cancer. The next two steps towards estabnlioshing this treatment for larger groups of patients include:

    1. To determine factors that predict response to LNG-IUD

    2. To determine long-term patient outcomes including survival, fertility, and patient needs.

  • Improving Quality of Survival for Women with Gynaecological Cancer

    • Focus on improving quality of life, health & function during & after gynaecological cancer treatment, with a focus on biomarker research, implementation research and cancer survivorship.

Supervision history

Current supervision

  • Doctor Philosophy

    Advanced methods for biomarker informed endometrial cancer

    Principal Advisor

    Other advisors: Dr Eva Baxter, Dr Zoe West, Professor Andrew Martin

  • Master Philosophy

    Patterns of care in endometrial cancer management in Queensland: a retrospective analysis.

    Principal Advisor

    Other advisors: Dr Eva Baxter

  • Doctor Philosophy

    Diet quality and composition in Australian women with endometrial cancer

    Associate Advisor

    Other advisors: Professor Monika Janda

Completed supervision

Enquiries

For media enquiries about Professor Andreas Obermair's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au